ConductScience.org, home

Paper · 31533396

The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility.

Lim CS and 7 others. Gut Liver, 2020. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility. Papers, record 31533396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31533396

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility.
PubMed
Journal
Gut Liver
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2021-09-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Pancreatic DuctalMajor topic
Pancreatic NeoplasmsMajor topic
Aged
Female
Humans
In Situ Hybridization, Fluorescence
Male
Middle Aged
Pancreatic Ducts

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in32,655,017Does the Cytogenetic Analysis Using Fluorescence In Situ Hybridization Improve the Preoperative Diagnostic Accuracy of Pancreatic Ductal Adenocarcinoma?https://conductscience.org/library/papers/32655017

Source PubMed

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117,889,705Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.Cancer Genet Cytogenet2007https://conductscience.org/library/papers/17889705PubMed
212,459,728Pancreatic cancer biology and genetics.Nat Rev Cancer2002https://conductscience.org/library/papers/12459728PubMed
319,525,336Statistical treatment of fluorescence in situ hybridization validation data to generate normal reference ranges using Excel functions.J Mol Diagn2009https://conductscience.org/library/papers/19525336PubMed
411,337,365Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis.Am J Pathol2001https://conductscience.org/library/papers/11337365PubMed
526,491,091Comparison of Ultrasound-Guided Core Needle Biopsy and Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Solid Pancreatic Lesions.J Ultrasound Med2015https://conductscience.org/library/papers/26491091PubMed
615,330,900A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.Am J Gastroenterol2004https://conductscience.org/library/papers/15330900PubMed
719,232,347A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.Gastroenterology2009https://conductscience.org/library/papers/19232347PubMed
819,247,032Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma.Ann Surg2009https://conductscience.org/library/papers/19247032PubMed
925,517,961Locus/chromosome aberrations in intraductal papillary mucinous neoplasms analyzed by fluorescence in situ hybridization.Am J Surg Pathol2015https://conductscience.org/library/papers/25517961PubMed
1010,980,115Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.Am J Pathol2000https://conductscience.org/library/papers/10980115PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42,279,399Maspin Modulates Malignant Phenotypes Depending on Subcellular Localization in Pancreatic Ductal Adenocarcinoma Cell Lines.Cancers (Basel)2026https://conductscience.org/library/papers/42279399PubMed
42,115,262Integrative multi-omics analysis identifies ATAD1 as a potential regulator of metastasis in pancreatic cancer.Sci Rep2026https://conductscience.org/library/papers/42115262PubMed
36,831,465Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy?Cancers (Basel)2023https://conductscience.org/library/papers/36831465PubMed
36,289,850Effects of the Exposure of Human Non-Tumour Cells to Sera of Pancreatic Cancer Patients.Biomedicines2022https://conductscience.org/library/papers/36289850PubMed
35,625,579Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool.Biomolecules2022https://conductscience.org/library/papers/35625579PubMed
32,655,017Does the Cytogenetic Analysis Using Fluorescence In Situ Hybridization Improve the Preoperative Diagnostic Accuracy of Pancreatic Ductal Adenocarcinoma?Gut Liver2020https://conductscience.org/library/papers/32655017PubMed

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDKN2A1,029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CEACAM31,084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
KRAS3,845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
MAFB9,935PubTator's text mininghttps://conductscience.org/library/genes/9935NCBI Gene
RUNX1861PubTator's text mininghttps://conductscience.org/library/genes/861NCBI Gene
RUNX1T1862PubTator's text mininghttps://conductscience.org/library/genes/862NCBI Gene
SMAD44,089PubTator's text mininghttps://conductscience.org/library/genes/4089NCBI Gene
TP537,157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31533396

GET https://conductscience.org/api/papers/v1/31533396/references?page=2